We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YAC.WS
1251
CALL
DELISTED
Yucaipa Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A
YAC.WS
$2.3M 0.01%
233,328
QCOM icon
1252
PUT
Qualcomm
QCOM
$174B
$2.29M 0.01%
+17,300
New +$2.5M
SMP icon
1253
Standard Motor Products
SMP
$898M
$2.29M 0.01%
+55,179
New +$2.34M
MSTR icon
1254
Strategy Inc
MSTR
$35.7B
$2.29M 0.01%
33,720
-55,760
-62% -$3.94M
UGI icon
1255
UGI
UGI
$7.98B
$2.28M 0.01%
+55,660
New +$2.15M
UPS icon
1256
CALL
United Parcel Service
UPS
$90.4B
$2.28M 0.01%
+13,400
New +$2.17M
SYK icon
1257
Stryker
SYK
$132B
$2.27M 0.01%
+9,319
New +$2.23M
VTGN icon
1258
VistaGen Therapeutics
VTGN
$9.63M
$2.26M 0.01%
+35,408
New +$2.36M
OHPAU
1259
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$2.25M 0.01%
+225,000
New +$2.25M
PTGX icon
1260
Protagonist Therapeutics
PTGX
$8.74B
$2.25M 0.01%
86,691
-30,103
-26% -$762K
SMTC icon
1261
Semtech
SMTC
$10.4B
$2.24M 0.01%
+32,513
New +$2.39M
BOKF icon
1262
BOK Financial
BOKF
$8.68B
$2.24M 0.01%
25,078
-40,209
-62% -$3.41M
NYT icon
1263
New York Times
NYT
$12.1B
$2.24M 0.01%
44,163
-46,823
-51% -$2.35M
INFI
1264
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$2.24M 0.01%
+691,892
New +$2.31M
SC
1265
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$2.24M 0.01%
82,636
-20,933
-20% -$525K
SDGR icon
1266
Schrodinger
SDGR
$1.15B
$2.23M 0.01%
29,298
-94,821
-76% -$8.53M
AMCR icon
1267
Amcor
AMCR
$21.5B
$2.22M 0.01%
38,064
+35,247
+1,251% +$2.01M
VIHAW
1268
CALL
DELISTED
VPC Impact Acquisition Holdings Warrant
VIHAW
$2.22M 0.01%
+171,138
New +$637K
TWNK
1269
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$2.22M 0.01%
154,853
-379,164
-71% -$5.57M
GS icon
1270
Goldman Sachs
GS
$308B
$2.22M 0.01%
6,790
-211,614
-97% -$65.9M
TGT icon
1271
CALL
Target
TGT
$65.6B
$2.22M 0.01%
+11,200
New +$2.1M
LEU icon
1272
Centrus Energy
LEU
$3.33B
$2.22M 0.01%
+93,465
New +$2.24M
NEM icon
1273
PUT
Newmont
NEM
$97.2B
$2.21M 0.01%
+36,700
New +$2.2M
META icon
1274
PUT
Meta Platforms (Facebook)
META
$1.51T
$2.21M 0.01%
+7,500
New +$2.02M
IMPX.WS
1275
CALL
DELISTED
AEA-Bridges Impact Corp Warrants
IMPX.WS
$2.21M 0.01%
224,997

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.